about
Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiencyPolymerase ε1 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo, and short stature ("FILS syndrome")Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damageEfficacy of gene therapy for X-linked severe combined immunodeficiencyFAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of functionExpansion of regulatory T cells in patients with Langerhans cell histiocytosisClinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency.Inherited MST1 deficiency underlies susceptibility to EV-HPV infectionsImmune deficiency-related enteropathy-lymphocytopenia-alopecia syndrome results from tetratricopeptide repeat domain 7A deficiency.Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans.Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome.Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national surveyNatural antibodies sustain differentiation and maturation of human dendritic cells.Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey.Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.Allogeneic bone marrow transplantation in mevalonic aciduria.Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency.Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency.Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF-α mAbs.Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
P50
Q24301912-869B9456-7CEE-4677-90F5-781F7FDCA122Q24598434-1550BAF7-DC62-44F6-A74E-B7FF73E82182Q24603171-20A052BB-D009-4A41-982A-577BBEB2D5FAQ28288838-969121F7-F52B-4F45-A170-EB832297953DQ28307801-8F71C1F3-9E53-45C8-AB5A-B6DF354CBB49Q28757236-E40928C7-A6C1-4408-9E83-781C8E022A93Q33359560-2C84AE3B-92D9-4A46-B68C-4EF5EDE33BB4Q34406086-33B6E5F2-5170-4BA5-B488-E360AF1073F4Q34436140-07024275-236C-4A76-958F-8CC8F78B914EQ35105055-FF23B413-453A-48F5-8160-7978079659F1Q36350966-933BFEDC-A22D-40E0-B2EA-A70D65036306Q36923083-A58F612D-032C-4B87-A07F-5B7C4AFE3BE8Q37557503-380E3293-B8BE-4C7E-801A-FE7C55BB8DF9Q37955638-B3564CD2-45DF-43AB-AA06-1281048A883BQ39330626-759AB69A-7B46-477B-8491-BED52C525356Q40446064-E4967DA6-5F88-47A6-B5A8-FE8DF53B8458Q44243015-CD26AE7E-5F21-4AA1-9D84-E0C1D8C37599Q44439263-D26699A3-10FA-4AD8-A4EF-6F4C7720C63BQ44603463-BDAE191D-A97F-421D-9594-12A658A9EEF6Q44912283-50B95367-638E-408E-B1E1-D4A832F608C0
P50
description
onderzoeker
@nl
name
Marianne Debré
@ast
Marianne Debré
@en
Marianne Debré
@es
Marianne Debré
@nl
Marianne Debré
@sl
type
label
Marianne Debré
@ast
Marianne Debré
@en
Marianne Debré
@es
Marianne Debré
@nl
Marianne Debré
@sl
prefLabel
Marianne Debré
@ast
Marianne Debré
@en
Marianne Debré
@es
Marianne Debré
@nl
Marianne Debré
@sl